Skip to content

Pharmacy CDS tools spotty at identifying drug-drug interactions

01/25/2011
Head on over the the ASHP list serv for an active, lively and good discussion of drug interactions, based on this intial post.  If you do not have access, we will attempt to write up a summary of all the action in the coming weeks. Any comments welcomed here as well. ______________________________________________________________________________________________

Is it me, or is this an embarrassment?   Must be an Arizona thing, this cannot possibly be happening in Massachusetts?  <tongue in cheek>

What are "we" going to do about it?  Interested in what folks think the solution might be.

 

http://www.cmio.net/index.php?option=com_articles&view=article&id=25739&division=cmio

JAMIA: Pharmacy CDS tools spotty at identifying drug-drug interactions

 

Many pharmacy clinical decision-support (CDS) systems don't always identify well-known, clinically relevant drug-drug interactions (DDIs), according to a study in the January edition ofJournal of the American Medical Informatics Association.

Pharmacy CDS software that contains DDI information can augment pharmacists' ability to detect clinically significant interactions, wrote lead author Kim R. Saverno, a graduate assistant in the Department of Pharmacy Practice and Science at the University of Arizona College of Pharmacy in Tucson, and colleagues. “However, studies indicate these systems may miss some important interactions. The purpose of this study was to assess the performance of pharmacy CDS programs to detect clinically important DDIs.”

Researchers made on-site visits to 64 participating Arizona pharmacies between December 2008 and November 2009 to analyze the ability of pharmacy information systems and associated CDS to detect DDIs. 

Software evaluation was conducted to determine whether DDI alerts arose from prescription orders entered into the pharmacy computer systems for a standardized fictitious patient. The fictitious patient's orders consisted of 18 different medications, including 19 drug pairs—13 of which were clinically significant DDIs, and six that were non-interacting drug pairs.

The sensitivity, specificity, positive predictive value, negative predictive value and percentage of correct responses were measured for each of the pharmacy CDS systems.

Only 18 (28 percent) of the 64 pharmacies correctly identified eligible interactions and non-interactions, the authors found. The median percentage of correct DDI responses was 89 percent (range 47–100 percent) for participating pharmacies. The median sensitivity to detect well-established interactions was 0.85 (range 0.23–1.0); median specificity was 1.0 (range 0.83–1.0); median positive predictive value was 1.0 (range 0.88–1.0) and median negative predictive value was 0.75 (range 0.38–1.0).

“Comprehensive system improvements regarding the manner in which pharmacy information systems identify potential DDIs are warranted,” the authors concluded.

Last Updated ( Wednesday, January 05 2011 )


Link to source article in JAMIA (full text and pdf currently free):

http://jamia.bmj.com/content/18/1/11.abstract

Posted via email

Advertisements
No comments yet

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: